0001457612-18-000069.txt : 20180625
0001457612-18-000069.hdr.sgml : 20180625
20180625200758
ACCESSION NUMBER: 0001457612-18-000069
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180621
FILED AS OF DATE: 20180625
DATE AS OF CHANGE: 20180625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BATE KENNETH
CENTRAL INDEX KEY: 0001210238
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36289
FILM NUMBER: 18918091
MAIL ADDRESS:
STREET 1: C/O MILLENNIUM PHARMACEUTICALS INC
STREET 2: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOCEA BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001457612
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 510596811
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-876-8191
MAIL ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: GENOCEA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090304
4
1
wf-form4_152997166026024.xml
FORM 4
X0306
4
2018-06-21
0
0001457612
GENOCEA BIOSCIENCES, INC.
GNCA
0001210238
BATE KENNETH
C/O GENOCEA BIOSCIENCES, INC.
100 ACORN PARK DRIVE, 5TH FLOOR
CAMBRIDGE
MA
02140
1
0
0
0
Stock Option (Right to Buy)
0.99
2018-06-21
4
A
0
45000
0
A
2019-06-21
2028-06-21
Common Stock
45000.0
45000
D
The option vests 100% on the first anniversary of the grant date.
/s/ William Clark, Attorney-in-fact
2018-06-25